Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chemotherapy Resistance and Sensitivity Testing in Lung Tumors

This study has been completed.
Cabell Huntington Hospital
Information provided by (Responsible Party):
Pier Paolo Claudio, M.D., Ph.D., Marshall University Identifier:
First received: March 19, 2012
Last updated: April 25, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)